-3 C°
Traffic jam:   2

Elon Musk conducted a study of immunity to COVID-19 on volunteers from SpaceX

21 February 2021
2 min.
Elon Musk conducted a study of immunity to COVID-19 on volunteers from SpaceX

Covid-19 immunity study

In total, more than 4,000 company employees were tested. The authors of the study, which included the founder of SpaceX, concluded that a certain level of antibodies could provide longer-lasting immunity.

SpaceX has conducted a coronavirus antibody study involving more than 4,000 volunteer employees of the company, The Wall Street Journal reports.

The study was led by SpaceX founder and CEO Elon Musk and executives from the company's medical division. It was attended by 4.3 thousand volunteers from among employees of SpaceX. The testing was conducted from April to June 2020.

The authors of the study, among whom Musk is listed, published the results of their work. From them, it follows that a certain threshold of antibodies can provide longer protection against coronavirus. The study also showed that people who had had COVID-19 in a milder form and with fewer symptoms produced fewer antibodies and were therefore less likely to meet the threshold for longer-term immunity.

According to scientists who studied immunity formation in SpaceX employees, the results of the study can be used to determine who is most vulnerable to the coronavirus and should be vaccinated first. For example, people without antibodies who are in places with a high incidence of the disease could be given priority.

Elon Musk took four coronavirus tests in November, two of which were positive and two were negative. According to the entrepreneur, these tests were from the same company and were taken by the same nurse.

The link between the severity of COVID-19 and the strength of the immunity received afterwards has been reported by the World Health Organization. They have recommended that those who have been mildly or asymptomatically infected should be vaccinated as not everyone develops sufficiently strong immunity after such an illness.

Soumya Swaminathan, a senior WHO researcher, explained that in this case the vaccination would boost the immune response.

Persons2 and Companies3 in the news

Chief scientific officer of World Health Organization
1 place
CEO of Tesla
2 place


Rating companies
43 Mention
39 Mention
36 Mention
36 Mention
Dow Jones
32 Mention
32 Mention
White House
30 Mention


News from GlobalNY.biz is the freshest and most relevant information about high-profile events in the region. The task of the resource's news feed is to convey to readers with maximum accuracy and objectivity information about important events in business, politics, economy, healthcare, culture and other spheres of life in New York.
GlobalNY.biz news is a coverage of economic processes taking place in New York, the latest news of public life, incidents and an overview of political events. New York news is information about the activities of small and medium-sized businesses, the work of housing and communal services and utilities, the implementation of significant projects.
The site's journalists describe not only the life of the region, but also talk about the current state of the US economy. Everything you need to know about innovations in the field of industry and agriculture, economy and power is collected in the "News" section at GlobalNY.biz.
New York news quickly informs the reader, shows the real picture and opens up hot topics. Communication with government structures and business enables us to provide our readers with reliable, information-rich material. The main page of the portal contains the key news of New York!
Alena Potapova

Development Director